Last updated: 2026-09-05 06:44:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Quanterix Corporation (QTRX) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $2.69, with a market capitalization of $123.43M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.15 to $8.77. This page covers its latest market performance, valuation, price trends and company information.
$123.43M | |
$2.58 | |
$92.57 | |
$2.15 | |
$2.58 | |
216.16K | |
-- | |
-- | |
$8.77 | |
$2.15 | |
-- | |
-- |
Quanterix Corporation (QTRX) last closed at $2.58 as of 2026-09-04 23:31:00, unchanged from the previous close of $2.58.
During the latest regular trading session, QTRX traded between $2.15 and $92.57, with a volume of 216.16K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Quanterix Corporation (QTRX) moved from $2.62 to $2.69, representing a gain of 2.48% ($0.06).
The stock traded between $2.57 and $2.70 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 521.78 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.1%
QTRX is currently trading at $2.69, placing it 8.1% of the way from its 52-week low of $2.15 to its 52-week high of $8.77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 450 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Quanterix Corporation (QTRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.